Clinical Trial Update: A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of GFA-918 on serum triglyceride levels in individuals with elevated triglycerides has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• GFA-918

Snippet

Sponsor: BIO-CAT Microbials, LLC | Conditions: Elevated Triglycerides | Phase 2 | Status: COMPLETED